UFP Technologies (NASDAQ:UFPT) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?

UFP Technologies, Inc. (NASDAQ:UFPT)’s share price passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $241.88 and traded as high as $288.44. UFP Technologies shares last traded at $285.20, with a volume of 91,734 shares changing hands.

Analyst Ratings Changes

A number of research firms have recently commented on UFPT. Wall Street Zen raised shares of UFP Technologies from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Weiss Ratings raised shares of UFP Technologies from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, August 5th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, UFP Technologies presently has a consensus rating of “Hold”.

UFP Technologies Price Performance

The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.72 and a current ratio of 3.00. The firm has a market cap of $2.31 billion, a P/E ratio of 32.16 and a beta of 1.08. The company has a 50-day moving average of $286.22 and a 200 day moving average of $242.48.

UFP Technologies (NASDAQ:UFPT) last announced its quarterly earnings results on Monday, August 3rd. The industrial products company reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.31 by $0.61. UFP Technologies had a return on equity of 18.42% and a net margin of 11.45%.The firm had revenue of $173.96 million for the quarter, compared to analysts’ expectations of $159.38 million. On average, sell-side analysts anticipate that UFP Technologies, Inc. will post 10.54 EPS for the current year.

Insider Activity

In related news, Director Cynthia Feldmann sold 1,000 shares of the stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $324.26, for a total transaction of $324,260.00. Following the completion of the sale, the director owned 4,476 shares in the company, valued at $1,451,387.76. This trade represents a 18.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Symeria Hudson sold 298 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $319.11, for a total transaction of $95,094.78. Following the sale, the director directly owned 927 shares in the company, valued at $295,814.97. This represents a 24.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 25,919 shares of company stock worth $8,173,084 in the last quarter. 4.59% of the stock is owned by company insiders.

Institutional Trading of UFP Technologies

Several large investors have recently made changes to their positions in UFPT. Bank of America Corp DE boosted its position in UFP Technologies by 20.7% in the 1st quarter. Bank of America Corp DE now owns 54,732 shares of the industrial products company’s stock valued at $10,596,000 after buying an additional 9,404 shares during the last quarter. Rice Hall James & Associates LLC boosted its holdings in UFP Technologies by 110.0% in the first quarter. Rice Hall James & Associates LLC now owns 21,211 shares of the industrial products company’s stock valued at $4,106,000 after acquiring an additional 11,111 shares during the last quarter. Diamond Hill Capital Management LLC Investment Advisor acquired a new stake in UFP Technologies in the second quarter worth about $14,629,000. De Lisle Partners LLP acquired a new position in UFP Technologies during the 2nd quarter valued at about $19,677,000. Finally, The Manufacturers Life Insurance Company bought a new position in shares of UFP Technologies in the 2nd quarter valued at about $989,000. Institutional investors own 87.28% of the company’s stock.

UFP Technologies Company Profile

UFP Technologies, Inc is a designer and contract manufacturer of comprehensive solutions for the medical device industry. The company works with medical technology companies to develop and produce components, subassemblies, finished devices, and sterile or non-sterile packaging used in surgical, diagnostic, therapeutic, and other healthcare applications.

Its capabilities include product development and engineering, precision machining, injection molding, thermoforming, textile fabrication, bonding, assembly, and packaging.